Avanir Pharmaceuticals Inc will reduce its employee headcount by 11% or 73 employees. The job cuts are expected to be completed by the end of January of the new year.
Depomed Inc (NASDAQ:DEPO) is looking to cut 40% of its staff as it shops around its best-selling drug and shuts down its current headquarters, all in an effort to reduce costs and stem the losses it has experienced over the year. The Depomed layoffs in 2018 will be a result of a weak performance by the (more…)
Charles River Layoffs Will Take Affect March 2018 Charles River Laboratories Intl. Inc. (NYSE:CRL) recently announced that it will be laying off 57 employees. The company’s plan is to shut down its facility in Frederick, Maryland. The Charles River layoffs will begin in March 2018, and the shutdown is expected to be completed five months (more…)
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is expected to announce a cost-cutting program in the coming weeks that will include the laying off of “tens of percents” of its 10,000 employees. The generic drugmaker could eliminate up to 25% of its workforce in Israel, where it employs 6,860 people and a few thousand more jobs in (more…)
Hundreds of people are now joining the increasing number of layoffs from generic drugmaker Mylan NV (NASDAQ:MYL), as the pharmaceutical company contends with bad press and subsequently weak earnings reports. The Mylan layoffs in 2017 are part of cost-saving measures and the latest round of U.S. job cuts hitting West Virginia. Mylan has also had (more…)
PPD Layoffs Part of Challenges in the Pharma Industry America’s pharma industry is continuing to shed more jobs each passing day. Wilmington, North Carolina-based contract research organization (CRO) Pharmaceutical Product Development, LLC (PPD) is cutting an undisclosed number of jobs in its hometown and in The Research Triangle (an area of North Carolina), in what seems like a cost-cutting (more…)
America’s retail and manufacturing sectors are not the only ones to have witnessed mass layoffs this year. Employees of Big Pharma were likewise hit with mass job cuts. Dominating these pharma layoffs in 2017 have been some of the most established names in the industry including Merck & Co., Inc. (NYSE:MRK), Eli Lilly and Co (more…)
The Medicines Company to Lay Off 85% of Employees The Medicines Company (NYSE:MDCO) announced that it is moving ahead with its previously announced restructuring plans. The company says that, over the next 45 days, it will cut its headcount to fewer than 60 people. The Medicines Company currently employs around 410 people, so a reduction (more…)
Merck Layoffs to Affect 1,800 U.S. Sales Representatives in 2017 Leading pharmaceutical company Merck & Co., Inc. has announced over 800 mass job cuts as it makes changes to its U.S. sales teams. The Merck layoffs will affect the company’s U.S. sales reps as it shifts its focus toward its top-selling drugs, where it sees growth. The (more…)
250 Workers to Lose their Jobs as Alexion Shutters Plant Rare-disease drug manufacturer Alexion Pharmaceuticals, Inc. has announced that the company is permanently closing its manufacturing site in Smithfield, Rhode Island, as part of a restructuring move.